CHECKPOINT THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 USD | +0.72% |
|
-2.78% | -38.86% |
Chart calendar Checkpoint Therapeutics, Inc.
4d25f2375960ee237.8Et85j4yz7NZxLji3JyHuWmXrSguWwB5eGNhzuzWl2M.ozoJy31Xv90uhdGmifvD0V3hlEF_KEE_S1NUr7rn_1e_BziUDnSXgA-WgA~76e8f723e219ce8fd0301107070ae071
Upcoming events on Checkpoint Therapeutics, Inc.
Past events on Checkpoint Therapeutics, Inc.
| 2024-03-22 08:30 am | Q4 2023 Earnings Release |
| 2024-01-18 04:00 pm | B. Riley Securities Oncology Conference |
| 2023-11-13 05:00 pm | Q3 2023 Earnings Release |
| 2023-09-28 10:20 am | Cantor Global Healthcare Conference |
| 2023-09-11 02:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:15 pm | Q2 2023 Earnings Release |
| 2023-06-12 10:00 am | Annual General Meeting |
| 2023-05-15 04:15 pm | Q1 2023 Earnings Release |
| 2023-03-30 | Q4 2022 Earnings Release |
| 2023-01-18 11:00 am | B. Riley Securities Oncology Conference |
| 2022-11-03 | Q3 2022 Earnings Release (Projected) |
| 2022-09-29 10:30 am | Ladenburg Thalmann Healthcare Conference |
| 2022-09-28 01:45 pm | Cantor Oncology, Hematology & HemeOnc Conference |
| 2022-09-13 | Lake Street Capital Markets Best Ideas Growth Conference |
| 2022-09-13 08:30 am | H.C. Wainwright Global Investment Conference |
| 2022-08-12 08:00 am | Interim 2022 Earnings Release |
| 2022-06-15 10:00 am | Annual General Meeting |
| 2022-06-06 02:15 pm | American Society of Clinical Oncology Meeting - Abstract Number - 9537 |
| 2022-05-25 03:00 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 04:30 pm | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,71 2,09 -18.45% | 1,07 1,11 -3.74% | 0,27 0,36 -25.72% | 0,19 0,15 30.43% | 0,10 0,12 -16.6% | 0,89 |
|
EBITDA Million USD | Released Forecast Spread | -24,9 -21,4 -16.12% | -23,2 -18,0 -28.89% | -56,7 -33,8 -67.82% | -58,3 -41,3 -41.24% | -52,1 -67,2 22.4% | -44,6 |
|
EBIT Million USD | Released Forecast Spread | -24,9 -22,3 -11.31% | -23,2 -18,1 -28.13% | -56,7 -38,6 -47.06% | -58,3 -52,7 -10.67% | -52,1 -57,4 9.22% | -47,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,7 -22,3 -11.04% | -23,1 -18,0 -28% | -56,7 -38,7 -46.55% | -62,6 -54,7 -14.42% | -51,8 -48,9 -6.12% | -51,7 |
|
Net income Million USD | Released Forecast Spread | -24,7 -22,3 -11.04% | -23,1 -18,0 -28% | -56,7 -38,7 -46.47% | -62,6 -53,9 -16.25% | -51,8 -48,9 -6.12% | -51,7 |
|
EPS USD | Released Forecast Spread | -7,00 -6,50 -7.69% | -4,10 -3,23 -27.13% | -7,50 -5,08 -47.64% | -7,09 -4,73 -49.96% | -3,17 -2,68 -18.28% | -1,50 |
| Announcement Date | 11/03/20 | 09/03/21 | 28/03/22 | 31/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,07 -77.14% | 0,05 0,00 - | 0,02 0,01 28.57% | 0,05 0,00 - | 0,07 0,03 131.25% | 0,04 0,01 180% | 0,03 0,01 520% | 0,03 0,01 148% | 0,01 0,02 -73.33% | 0,01 | 0,01 | 0,05 | 0,01 | 0,71 |
|
EBITDA Million USD | Released Forecast Spread | -29,8 -9,20 -223.59% | -14,2 -11,0 -28.76% | -16,6 -4,00 -316.1% | -18,1 -14,8 -22.18% | -16,2 -15,7 -3.15% | -16,3 | -10,2 -17,1 40.53% | -10,5 | -10,7 | -21,2 | -11,0 | -12,3 | ||
|
EBIT Million USD | Released Forecast Spread | -29,8 -13,2 -125.36% | -16,9 -12,1 -39.04% | -14,2 -14,0 -1.41% | -10,7 -13,5 21.09% | -16,6 -14,8 -12.33% | -18,1 -13,6 -33.19% | -16,2 -14,1 -14.86% | -7,70 -14,8 48.13% | -10,2 -10,6 3.82% | -7,23 | -7,28 | -8,11 | -8,97 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,8 -12,2 -143.82% | -16,8 -12,1 -38.93% | -14,1 -14,6 2.99% | -10,6 -13,5 21.47% | -21,0 -13,1 -60.37% | -10,5 -14,0 24.92% | -16,5 -14,5 -13.94% | -5,72 -15,7 63.62% | -19,1 -13,7 -39.4% | -8,25 | -8,36 | -20,7 | -9,01 | -10,0 |
|
Net income Million USD | Released Forecast Spread | -29,8 -12,2 -143.82% | -16,8 -12,1 -38.93% | -14,1 -14,3 1.39% | -10,6 -13,5 21.47% | -21,0 -13,1 -60.37% | -10,5 -14,0 24.92% | -16,5 -14,5 -13.94% | -5,72 -15,7 63.62% | -19,1 -13,7 -39.4% | -8,25 | -8,36 | -20,7 | -9,01 | -10,0 |
|
EPS USD | Released Forecast Spread | -3,90 -1,54 -153.25% | -2,00 -1,45 -37.93% | -1,60 -1,62 1.23% | -1,20 -1,47 18.18% | -6,61 -1,31 -406.13% | -0,89 -1,07 16.56% | -1,05 -0,78 -34.62% | -0,29 -0,76 61.84% | -1,10 -0,58 -91.3% | -0,27 | -0,27 | -0,73 | -0,28 | -0,30 |
| Announcement Date | 28/03/22 | 12/05/22 | 12/08/22 | 08/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 22/03/24 | - | - | - | - | - |
| Today 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
| Today 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| Today 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| Today 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-05 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Checkpoint Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CKPT Stock
- Calendar Checkpoint Therapeutics, Inc.
